A spontaneous report is an unsolicited communication by a healthcare professional or consumer to a company, regulatory authority, or other organization that describes one or more adverse drug reactions in a patient who was given one or more medicinal products. These reports are typically submitted voluntarily when an unexpected or concerning event occurs during normal clinical practice.
Spontaneous reports play a crucial role in post-marketing drug safety surveillance, helping to identify potential new adverse reactions or changes in the severity or frequency of known side effects. While they have limitations, such as potential underreporting and lack of denominator data, spontaneous reports are valuable for generating safety signals and hypotheses for further investigation.
Spontaneous reports are crucial in clinical research as they provide real-world data on drug safety and efficacy beyond controlled clinical trials. They allow researchers and regulatory authorities to identify potential adverse reactions that may not have been observed during pre-market studies, contributing to ongoing safety assessments of marketed drugs.
The importance of spontaneous reports lies in their ability to detect rare or long-term side effects that may not be apparent in shorter-duration clinical trials. This information helps in updating product labels, issuing safety alerts, and guiding further research, ultimately enhancing patient safety and improving the overall understanding of a drug’s risk-benefit profile.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2026 Axcellant